Added over 5,500 net new locations in first quarter 2023
Annualized recurring run-rate as of March 31, 2023 grew 55% year-over-year
First quarter gross profit grew 96% and non-GAAP gross profit grew. | May 9, 2023
The information in this discussion contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of. | May 5, 2023
PIOMBINO DESE, Italy (BUSINESS WIRE) Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology
- Reiterates Full Year 2023 Guidance - Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology